Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from Focus Diagnostics

Journal of Clinical Virology

Volumn 44, Issue 2, 2009, Pages 125-128

  Leyland, Bridget ^a   Kennedy, Margaret R ^b   Wimberly, Yolanda H ^c   Levine, Bruce J ^d   Cherpes, Thomas L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

^d Phoenix Ob Gyn Associates   (United States)

Author keywords

HSV 2 serodiagnosis; Point of care testing; Pregnancy

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS DIAGNOSIS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; GEORGIA; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MIDDLE AGED; NEW JERSEY; PENNSYLVANIA; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 59849084078     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.11.009     Document Type: Article

References (28)

1. Fleming D.T., McQuillan G.M., Johnson R.E., Nahmias A.J., Aral S.O., Lee F.K., et al. Herpes simplex virus type 2 in the United States 1976 to 1994. N Engl J Med 337 (1997) 1105-1111
2. Benedetti J., Corey L., and Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 121 (1994) 847-854
3. Mertz G.J., Benedetti J., Ashley R., Selke S., and Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 116 (1992) 197-202
4. Freeman E.E., Weiss H.A., Glynn J.R., Cross P.L., Whitworth J.A., and Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20 (2006) 73-83
5. Corey L., Wald A., Celum C.L., and Quinn T.C. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 35 (2004) 435-445
6. Brown Z.A., Vontver L.A., Benedetti J., Critchlow C.W., Sells C.J., Berry S., et al. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 317 (1987) 1246-1251
7. Brown Z.A., Benedetti J., Ashley R., Burchett S., Selke S., Berry S., et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 324 (1991) 1247-1252
8. Corey L., and Handsfield H.H. Genital herpes and public health: addressing a global problem. JAMA 283 (2000) 791-794
9. Ashley R., Cent A., Maggs V., Nahmias A., and Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann Intern Med 115 (1991) 520-526
10. Dolan A., Jamieson F.E., Cunningham C., Barnett B.C., and McGeoch D.J. The genome sequence of herpes simplex virus type 2. J Virol 72 (1998) 2010-2021
11. Ashley R.L., Militoni J., Lee F., Nahmias A., and Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 26 (1988) 662-667
12. Wutzler P., Doerr H.W., Färber I., Eichhorn U., Helbig B., Sauerbrei A., et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 61 (2000) 201-207
13. Prince H.E., Ernst C.E., and Hogrefe W.R. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal 14 (2000) 13-16
14. Ashley R.L., Eagleton M., and Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol 37 (1999) 1632-1633
15. Ashley R.L. Sorting out the new HSV type specific antibody tests. Sex Transm Infect 77 (2001) 232-237
16. Mark H.D., Nanda J.P., Roberts J., Rompalo A., Melendez J.H., and Zenilman J. Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes. Sex Transm Dis 34 (2007) 681-685
17. Handsfield H.H., Stone K.M., and Wasserheit J.N. Prevention agenda for genital herpes. Sex Transm Dis 26 (1999) 228-231
18. Ashley-Morrow R., Nollkamper J., Robinson N.J., Bishop N., and Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 10 (2004) 530-536
19. Hogrefe W., Su X., Song J., Ashley R., and Kong L. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol 40 (2002) 3635-3640
20. Morrow R.A., Friedrich D., Meier A., and Corey L. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA. BMC Infect Dis 5 (2005) 84-90
21. Cherpes T.L., Wiesenfeld H.C., Melan M.A., Kant J.A., Cosentino L.A., Meyn L.A., et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 33 (2006) 747-752
22. Ribes J.A., Hayes M., Smith A., Winters J.L., and Baker D.J. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics. J Clin Microbiol 39 (2001) 3740-3742
23. Brown Z.A., Selke S., Zeh J., Kopelman J., Maslow A., Ashley R.L., et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 337 (1997) 509-515
24. Prober C.G., Corey L., Brown Z.A., Hensleigh P.A., Frenkel L.M., Bryson Y.J., et al. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 15 (1992) 1031-1038
25. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006; 55, 6-8.
26. Guerry S.L., Bauer H.M., Klausner J.D., Branagan B., Kerndt P.R., Allen B.G., et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis 40 (2005) 38-45
27. Gardella C., Brown Z., Wald A., Selke S., Zeh J., Morrow R.A., et al. Risk factors for herpes simplex virus transmission to pregnant women: a couples study. Am J Obstet Gynecol 193 (2005) 1891-1899
28. Lindsay M.K. HSV neutralizing antibodies further refinement in preventing neonatal herpes infection. Am J Obstet Gynecol 195 (2006) 4-6